Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Alnylam Presents New Pre-Clinical Data On RNAi Therapeutics Targeting Transthyretin (TTR) For The Treatment Of TTR-Mediated Amyloidosis (ATTR)

 

Alnylam Presents New Pre-Clinical Data On RNAi Therapeutics Targeting Transthyretin (TTR) For The Treatment Of TTR-Mediated Amyloidosis (ATTR)

2014-04-30 06:24:19| drugdiscoveryonline News Articles

Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company, recently announced the presentation of new pre-clinical data on RNAi therapeutics targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR)

Tags: data treatment presents targeting

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

03.07 Nebraska celebrates new feedlot research, teaching, extension center 03.07 Hurricane Beryl Public Advisory Number 20A 03.07 Summary for Hurricane Beryl (AT2/AL022024) 03.07 Eastern North Pacific Tropical Weather Outlook 03.07 Atlantic Tropical Weather Outlook 03.07 Genesus to restructure with Canada ZF Investments 03.07 Global trade, domestic policy: What's at stake for pork industry 03.07 Over 20,000 Tesco staff to split 30m from share schemes More »